HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Coraline Dumenil Selected Research

Neoplasms (Cancer)

11/2022Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab.
3/2021Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer.
1/2020Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression.
10/2019Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab.
8/2019Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection?
1/2019Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients.
1/2018Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab.
1/2018Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer.
3/2013Bilateral pneumothorax complicating cystic metastases of bronchial squamous cell carcinoma under erlotinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Coraline Dumenil Research Topics

Disease

11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 01/2017
9Neoplasms (Cancer)
11/2022 - 03/2013
2Lung Neoplasms (Lung Cancer)
11/2022 - 01/2018
1Adenocarcinoma of Lung
01/2020
1Adenocarcinoma
11/2018
1Brain Neoplasms (Brain Tumor)
01/2018
1Fistula
03/2013
1Necrosis
03/2013
1Neoplasm Metastasis (Metastasis)
03/2013
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2013
1Pneumothorax
03/2013

Drug/Important Bio-Agent (IBA)

6Immune Checkpoint InhibitorsIBA
03/2021 - 01/2018
5NivolumabIBA
10/2019 - 01/2017
3Biomarkers (Surrogate Marker)IBA
12/2020 - 01/2018
2Circulating Tumor DNAIBA
01/2020 - 01/2018
2Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2018 - 03/2013
1pembrolizumabIBA
11/2022
1beta CateninIBA
03/2021
1Wnt1 ProteinIBA
03/2021
1Anti-Bacterial Agents (Antibiotics)IBA
10/2019
1CitrullineIBA
10/2019
1Bacterial DNAIBA
10/2019
1B7-H1 AntigenIBA
08/2019
1CotinineIBA
01/2019
1PlatinumIBA
01/2019
1Tyrosine Kinase InhibitorsIBA
11/2018
1CrizotinibIBA
11/2018
1osimertinibIBA
11/2018

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2019 - 03/2013
1Immunotherapy
01/2017
1Therapeutics
01/2017